Bicycle Therapeutics Plc (BCYC)
3.60
+0.09
(+2.56%)
USD |
NASDAQ |
Oct 15, 16:00
3.89
+0.29
(+8.06%)
After-Hours: 04:11
Bicycle Therapeutics Cash from Operations (TTM) : -205.24M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -205.24M |
| March 31, 2026 | -229.37M |
| December 31, 2025 | -250.26M |
| September 30, 2025 | -239.93M |
| June 30, 2025 | -209.79M |
| March 31, 2025 | -180.67M |
| December 31, 2024 | -164.79M |
| September 30, 2024 | -203.49M |
| June 30, 2024 | -164.00M |
| March 31, 2024 | -84.86M |
| December 31, 2023 | -60.86M |
| September 30, 2023 | -45.66M |
| June 30, 2023 | -49.61M |
| March 31, 2023 | -106.75M |
| December 31, 2022 | -86.06M |
| September 30, 2022 | -62.09M |
| Date | Value |
|---|---|
| June 30, 2022 | -35.24M |
| March 31, 2022 | -24.71M |
| December 31, 2021 | -14.79M |
| September 30, 2021 | -23.44M |
| June 30, 2021 | -55.15M |
| March 31, 2021 | -55.14M |
| December 31, 2020 | -17.93M |
| September 30, 2020 | -5.988M |
| June 30, 2020 | -7.412M |
| March 31, 2020 | -2.669M |
| December 31, 2019 | -28.73M |
| September 30, 2019 | -32.53M |
| June 30, 2019 | -25.98M |
| March 31, 2019 | -23.78M |
| December 31, 2018 | -26.02M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Autolus Therapeutics Plc | -224.98M |
| Akari Therapeutics Plc | -10.74M |
| Cellectis SA | -42.00M |
| DBV Technologies SA | -169.35M |
| Biodexa Pharmaceuticals Plc | -9.219M |